Main competitors
Dividend Yield (Y) Dividend Yield (Y+1) P/E (Y) Price to Book (Y) EV / Sales (Y) EV / EBITDA (Y) EV / EBIT (Y) Capi.($)
1.13%1.52%17.74x2.14x - - - 35Cr
0.71%0.8%27.6x17.08x10.48x21x22.35x 84TCr
2.22%2.34%25.27x6.41x5.88x15.98x17.65x 57TCr
3.33%3.46%23.1x144.54x6.26x12.64x13.02x 37TCr
1.62%1.72%25.82x5.72x5.33x14.9x15.96x 32TCr
2.78%2.86%28.22x5.34x5.02x15.65x18.52x 30TCr
2.86%2.99%21.36x6.43x5.74x13.88x15.18x 29TCr
2.86%3.06%23.42x16.7x6.07x10.8x13.78x 19TCr
2.34%2.39%19.15x6.24x5.87x10.62x12.5x 17TCr
4.46%4.68%11.58x4.86x4.13x8.67x10.19x 17TCr
4.31%4.43%11.88x5.07x3.13x8.28x9.03x 12TCr
3.21%3.49%13.83x4.5x2.91x8.43x9.6x 12TCr
5.3%5.64%11.77x1.25x2.31x7.42x8.21x 11TCr
-.--%-.--%24.88x4.94x7.51x16.77x17.43x 11TCr
1.58%1.75%28.23x6.29x9.66x18.17x19x 8.97TCr
3.49%3.55%51.28x1.27x2.87x10.59x30.05x 5.69TCr
0.47%0.54%40.49x5.45x9.23x30.77x32.09x 5.54TCr
0.55%1.91%19.98x1.41x1.58x7.58x12.99x 4.63TCr
Average 2.4% 2.62% 23.64x 13.65x 5.53x 13.66x 16.33x 21.86TCr
Weighted average by Cap. 2.25% 2.39% 24.05x 21.45x 6.52x 15.07x 16.82x
Other Pharmaceuticals